Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 36250601000001113 | Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 36250701000001115 | Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 70045101000001116 | Kaletra 200mg/50mg tablets (AbbVie Ltd) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet | Has AMP | True | Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) | Inferred relationship | Existential restriction modifier | |
| Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) 120 tablet | Is pack of | False | Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) | Inferred relationship | Existential restriction modifier | |
| Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) 120 tablet | Has AMP | True | Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets